Hillsdale Investment Management »

Relmada Therapeutics shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $373k 54k 6.96

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Enerflex (EFXT)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Manulife Finl Corp (MFC)
Fortis (FTS)
Centerra Gold (CGAU)
Barrick Mining Corp (B)
Precision Drill (PDS)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Suncor Energy (SU)

View all positions for Hillsdale Investment Management

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
Adage Capital Partners GP
OrbiMed Advisors
Marshall Wace
Millennium Management
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
Polar Capital Holdings
Susquehanna International
BlackRock
Vanguard Group

View all funds holding Relmada Therapeutics